MetaCap

eXoZymes Insider Trades

NASDAQ: EXOZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.91-0.475 (-14.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $6.41K
Sales
3 · $34.85K
Shares bought / sold
855 / 5.23K
Net activity
Net selling $28,446

eXoZymes insider activity

Over the last 12 months, eXoZymes insiders reported 17 transactions on SEC Form 4: 5 open-market purchases and 3 sales. Insiders bought $6,405 and sold $34,851 worth of stock, for net insider selling of $28,446. The largest seller was Perriman Damien Alan, with $19,427 in reported sales.

The most recent filing shows Perriman Damien Alan (Chief Commercial Officer) selling 3,729 shares at $5.21 on Oct 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put EXOZ's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

EXOZ insider transactions

eXoZymes insider transactions
DateInsiderTypeSharesValueFiling
Oct 12, 2026Perriman Damien AlanChief Commercial OfficerSale3,729$19.43KForm 4
Oct 9, 2026Perriman Damien AlanChief Commercial OfficerOption exercise3,922—Form 4
Aug 26, 2026Heltzen MichaelChief Executive OfficerBuy250$1.90KForm 4
Aug 26, 2026Heltzen MichaelChief Executive OfficerBuy251$1.84KForm 4
Aug 26, 2026Heltzen MichaelChief Executive OfficerBuy4$30.32Form 4
Aug 25, 2026Heltzen MichaelChief Executive OfficerBuy100$750Form 4
Aug 25, 2026Heltzen MichaelChief Executive OfficerBuy250$1.88KForm 4
Aug 19, 2026Korman Tyler PazChief Scientific OfficerOption exercise32,964—Form 4
Aug 19, 2026Perriman Damien AlanChief Commercial OfficerOption exercise19,612—Form 4
Aug 19, 2026Heltzen MichaelChief Executive OfficerAward8,841$56.58KForm 4
Apr 9, 2026Korman Tyler PazChief Scientific OfficerSale750$7.89KForm 4
Apr 8, 2026Korman Tyler PazChief Scientific OfficerSale750$7.53KForm 4
Apr 1, 2026Korman Tyler PazChief Scientific OfficerAward5,332$45.00KForm 4
Apr 1, 2026Nawaz FouadVice President- FinanceAward5,999$50.63KForm 4
Apr 1, 2026Opgenorth Paul HideoVice President, DevelopmentAward3,999$33.75KForm 4
Apr 1, 2026Perriman Damien AlanChief Commercial OfficerAward8,887$75.01KForm 4
Apr 1, 2026Perriman Damien AlanChief Commercial OfficerAward62,759—Form 4
Jul 2, 2025Heltzen MichaelChief Executive OfficerBuy1,040$10.63KForm 4
Jun 16, 2025Korman Tyler PazVice President, ResearchAward2,990$37.49KForm 4
Jun 13, 2025Nawaz FouadVice President, FinanceAward3,489$43.75KForm 4
Jun 13, 2025Opgenorth Paul HideoVice President, DevelopmentAward2,990$37.49KForm 4
Jan 17, 2025Heltzen MichaelChief Executive OfficerBuy1,767$19.05KForm 4
Jan 16, 2025Heltzen MichaelChief Executive OfficerBuy121$1.30KForm 4
Nov 15, 2024Heltzen MichaelChief Executive OfficerBuy1,984$22.02KForm 4
Nov 8, 2024MDB Capital Holdings, LLC10% OwnerConversion122,657$785.00KForm 4
Nov 8, 2024Opgenorth Paul HideoVice President, DevelopmentConversion2,344$15.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related